Cartesian Therapeutics (RNAC) Institutional Ownership $19.29 +0.36 (+1.90%) As of 01/17/2025 04:00 PM Eastern Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Institutional Ownership Changes (13F Filings) for Cartesian Therapeutics (NASDAQ:RNAC)CurrentInstitutional OwnershipPercentage86.95%Number ofInstitutional Buyers(last 12 months)19TotalInstitutional Inflows(last 12 months)$367.19MNumber ofInstitutional Sellers(last 12 months)6TotalInstitutional Outflows(last 12 months)$30.50M Get RNAC Insider Trade Alerts Want to know when executives and insiders are buying or selling Cartesian Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data RNAC Institutional Buying and Selling by Quarter Cartesian Therapeutics Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails12/26/2024JPMorgan Chase & Co.309,018$4.98M0.0%+0.9%1.216% 11/19/2024Barclays PLC11,611$188K0.0%+208.6%0.046% 11/16/2024Geode Capital Management LLC135,700$2.19M0.0%+2.1%0.534% 11/15/2024Barclays PLC11,611$188K0.0%+208.6%0.046% 11/15/2024State Street Corp157,495$2.54M0.0%+2.5%0.620% 11/15/2024Ikarian Capital LLC52,193$841K0.1%-78.5%0.205% 11/13/2024Great Point Partners LLC200,000$3.22M0.9%N/A0.787% 11/13/2024BNP Paribas Financial Markets1,651$27K0.0%+122.5%0.006% 11/13/2024FMR LLC2,851,830$45.97M0.0%+458.3%11.219% 10/23/2024Lake Street Advisors Group LLC15,822$255K0.0%-50.0%0.074% Get the Latest News and Ratings for RNAC and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Cartesian Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 9/16/2024Point72 DIFC Ltd1,725$47K0.0%N/A0.008% 9/16/2024Cubist Systematic Strategies LLC13,010$351K0.0%N/A0.061% 9/16/2024Point72 Asia Singapore Pte. Ltd.1,824$49K0.0%N/A0.009% 8/27/2024Logos Global Management LP90,000$2.43M0.2%N/A0.506% 8/15/2024Point72 Asia Singapore Pte. Ltd.1,824$49K0.0%N/A0.009% 8/14/2024Cubist Systematic Strategies LLC13,010$351K0.0%N/A0.061% 8/14/2024Point72 DIFC Ltd1,725$47K0.0%N/A0.008% 8/14/2024Marshall Wace LLP30,038$811K0.0%N/A0.140% 8/14/2024Logos Global Management LP90,000$2.43M0.2%N/A0.421% 8/9/2024Renaissance Technologies LLC17,052$461K0.0%-96.9%0.096% 8/6/2024Lake Street Advisors Group LLC31,644$855K0.0%N/A0.178% 8/1/2024Rhumbline Advisers8,487$229K0.0%-93.5%0.048% 7/26/2024Bank of New York Mellon Corp19,916$538K0.0%-93.7%0.112% 7/22/2024 Hall Laurie J Trustee1,759$48K0.0%-96.7%0.010% 5/17/2024Artal Group S.A.9,136,635$5.94M0.2%N/A171.098% 5/14/2024American International Group Inc.56,202$37K0.0%N/A1.052% 5/10/2024Vanguard Group Inc.6,315,113$4.11M0.0%N/A118.172% 5/7/2024 SG Americas Securities LLC47,134$31K0.0%N/A0.883% 5/3/2024Delphi Financial Group Inc.660,852$430K0.3%N/A12.261% 5/1/2024BNP Paribas Financial Markets59,125$38K0.0%N/A1.097% 4/23/2024 Hall Laurie J Trustee52,775$34K0.0%N/A0.979% (Data available from 1/1/2016 forward) RNAC Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of RNAC shares? During the previous two years, 23 institutional investors and hedge funds held shares of Cartesian Therapeutics. The most heavily invested institutionals were FMR LLC ($45.97M), Artal Group S.A. ($5.94M), JPMorgan Chase & Co. ($4.98M), Vanguard Group Inc. ($4.11M), Great Point Partners LLC ($3.22M), State Street Corp ($2.54M), and Logos Global Management LP ($2.43M).Learn more on RNAC's institutional investors. What percentage of Cartesian Therapeutics stock is owned by institutional investors? 86.95% of Cartesian Therapeutics stock is owned by institutional investors. Learn more on RNAC's institutional investor holdings. Which institutional investors have been buying Cartesian Therapeutics stock? Of the 19 institutional investors that purchased Cartesian Therapeutics stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Artal Group S.A. ($9.14M), Vanguard Group Inc. ($6.32M), FMR LLC ($2.34M), Delphi Financial Group Inc. ($660.85K), Great Point Partners LLC ($200K), Logos Global Management LP ($180K), and BNP Paribas Financial Markets ($60.03K). How much institutional buying is happening at Cartesian Therapeutics? Institutional investors have bought a total of 19,169,552 shares in the last 24 months. This purchase volume represents approximately $367.19M in transactions. Which Cartesian Therapeutics major shareholders have been selling company stock? The following institutional investors have sold Cartesian Therapeutics stock in the last 24 months: Renaissance Technologies LLC ($536.55K), Bank of New York Mellon Corp ($297.41K), Ikarian Capital LLC ($190.18K), Rhumbline Advisers ($121.40K), Hall Laurie J Trustee ($51.02K), and Lake Street Advisors Group LLC ($15.82K). How much institutional selling is happening at Cartesian Therapeutics? Institutional investors have sold a total of 1,212,365 shares in the last 24 months. This volume of shares sold represents approximately $30.50M in transactions. Related Companies APGE Institutional Ownership AMPH Institutional Ownership TARS Institutional Ownership IOVA Institutional Ownership IRON Institutional Ownership IBRX Institutional Ownership WVE Institutional Ownership BLTE Institutional Ownership GLPG Institutional Ownership ARQT Institutional Ownership This page (NASDAQ:RNAC) was last updated on 1/20/2025 by MarketBeat.com Staff From Our PartnersLast time you’ll see this priced at $1.00When was the last time you bought something for a buck? I don’t even think you can buy anything at McDonalds f...StocksToTrade | SponsoredBill Gates’ is about to mint millionaires (again) with Stargate.This little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredJanuary 29th - the next big trading catalyst to watch Mark your calendar for January 29th. Because on that day, I believe we could see a $2 Trillion shock INTO t...Timothy Sykes | SponsoredTop Picks for Trump’s Pro-Crypto AmericaThe Crypto ETF Windfall: 27 Experts Tell All (Free) Don't miss your chance to see exactly what crypto's eli...Crypto 101 Media | SponsoredWarren Buffett Bets $40 Billion—You Can Get in for $20I call it "The Last Retirement Stock You'll Ever Need." Warren Buffett himself owns $40 billion of stock in...Behind the Markets | SponsoredKamala’s final humiliation The investments connected to Trump's second term in ways that almost nobody outside his inner circle is aware ...Porter & Company | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cartesian Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Cartesian Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free RNAC Stock Alerts